Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-02-20 @ 3:51 PM
Study NCT ID:
NCT05579860
Status:
COMPLETED
Last Update Posted:
2024-05-10
First Post:
2022-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing Two Subcutaneous Formulations: Vial and Autoinjector (AI) With Olezarsen, at Two Dose Levels, in Healthy Adult Participants
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-11
First Submit QC Date:
None
Study First Post Date:
2022-10-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-09
Last Update Post Date:
2024-05-10
Last Update Post Date Type:
ACTUAL